Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4036 AL 4050

An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds

Zanforlin E, Zagotto G, Ribaudo G.

Curr Med Chem. 2017 Nov 17;24(34):3749-3773. doi: 10.2174/0929867324666170712161829.

Natural product for the treatment of Alzheimer's disease

Bui TT, Nguyen TH.

J Basic Clin Physiol Pharmacol. 2017 Sep 26;28(5):413-423. doi: 10.1515/jbcpp-2016-0147.

Targeting Fyn Kinase in Alzheimer's Disease

Nygaard HB.

Biol Psychiatry. 2018 Feb 15;83(4):369-376. doi: 10.1016/j.biopsych.2017.06.004. Epub 2017 Jun 13.

Antagonism of the 5-HT(6) receptor - Preclinical rationale for the treatment of Alzheimer's disease

de Jong IEM, Mørk A.

Neuropharmacology. 2017 Oct;125:50-63. doi: 10.1016/j.neuropharm.2017.07.010. Epub 2017 Jul 12.

Amyloid beta: structure, biology and structure-based therapeutic development

Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE.

Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. doi: 10.1038/aps.2017.28. Epub 2017 Jul 17.

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

Lin H, Li Q, Gu K, Zhu J, Jiang X, Chen Y, Sun H.

Curr Top Med Chem. 2017;17(27):3000-3016. doi: 10.2174/1568026617666170717114944.

Drug candidates in clinical trials for Alzheimer's disease

Hung SY, Fu WM.

J Biomed Sci. 2017 Jul 19;24(1):47. doi: 10.1186/s12929-017-0355-7.

BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease

Prati F, Bottegoni G, Bolognesi ML, Cavalli A.

J Med Chem. 2018 Feb 8;61(3):619-637. doi: 10.1021/acs.jmedchem.7b00393. Epub 2017 Aug 8.

Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease

Lee JK, Kim NJ.

Molecules. 2017 Aug 2;22(8):1287. doi: 10.3390/molecules22081287.

Smartphone-Based Health Technologies for Dementia Care: Opportunities, Challenges, and Current Practices

Brown EL, Ruggiano N, Li J, Clarke PJ, Kay ES, Hristidis V.

J Appl Gerontol. 2019 Jan;38(1):73-91. doi: 10.1177/0733464817723088. Epub 2017 Aug 4.

MicroRNA Dysregulation in Alzheimer's Disease

Putteeraj M, Fairuz YM, Teoh SL.

CNS Neurol Disord Drug Targets. 2017;16(9):1000-1009. doi: 10.2174/1871527316666170807142311.

Lessons from Anti-Amyloid-β Immunotherapies in Alzheimer Disease: Aiming at a Moving Target

Wang Y, Yan T, Lu H, Yin W, Lin B, Fan W, Zhang X, Fernandez-Funez P.

Neurodegener Dis. 2017;17(6):242-250. doi: 10.1159/000478741. Epub 2017 Aug 9.

Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents

Jouanne M, Rault S, Voisin-Chiret AS.

Eur J Med Chem. 2017 Oct 20;139:153-167. doi: 10.1016/j.ejmech.2017.07.070. Epub 2017 Jul 29.

Human induced pluripotent stem cells as a research tool in Alzheimer's disease

Robbins JP, Price J.

Psychol Med. 2017 Nov;47(15):2587-2592. doi: 10.1017/S0033291717002124. Epub 2017 Aug 14.

Effect of Chinese Herbal Medicine on Alzheimer's Disease

Howes MR, Fang R, Houghton PJ.

Int Rev Neurobiol. 2017;135:29-56. doi: 10.1016/bs.irn.2017.02.003. Epub 2017 Mar 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias